nach oben

Erschienen in:

01.08.2008

Association of Sleep Apnea Severity and Obesity with Insulin Resistance, C-Reactive Protein, and Leptin Levels in Male Patients with Obstructive Sleep Apnea

verfasst von: Fotis Kapsimalis, George Varouchakis, Asimina Manousaki, Spiros Daskas, Dimitra Nikita, Meir Kryger, Konstantinos Gourgoulianis

Erschienen in: Lung | Ausgabe 4/2008

Einloggen, um Zugang zu erhalten

Abstract

Obesity is the major confounding factor in the relationship between obstructive sleep apnea and increased risk for cardiovascular disease. The aim of the study was to investigate the association of sleep apnea severity with insulin resistance, leptin, and CRP levels in a cohort of male patients. Sixty-seven men referred to our sleep laboratory for evaluation of suspected obstructive sleep apnea syndrome (OSAS) were divided into three groups according to apnea severity: non-OSAS group (n = 15), mild to moderate OSAS group (n = 26), and severe OSAS (n = 26). Insulin resistance was estimated by the homeostasis model assessment method. HOMA values were similar in the three groups: (3.2 ± 2.2 vs. 3.3 ± 1.8 vs. 3.6 ± 1.5, respectively, p = 0.71). Leptin levels were higher in the mild to moderate OSAS group (23.1 ± 21.8 ng/ml, p < 0.05) and in the severe OSAS group (20.2 ± 17.5 ng/ml, p < 0.05) than in the non-OSAS group (9.4 ± 6.4 ng/ml). CRP levels were significantly higher in severe sleep apnea (0.35 ± 0.3 vs. 0.19 ± 0.1 mg/dl, p < 0.05). In multiple regression analyses, waist-to-hip ratio (WHR) was the most significant determinant of HOMA estimation for insulin resistance. WHR and the percentage of total sleep time spent with hypoxemia (%TST with SaO2 <90%) were significant predictors for leptin levels, while body mass index (BMI) and the %TST with SaO2 <90% were the best predicting parameters for CRP levels. Insulin resistance estimated by the HOMA method in male patients with OSAS was not associated with sleep apnea severity independent of obesity. The severity of nocturnal hypoxemia was associated with leptin and CRP levels independent of obesity.

Nieto FJ, Young TB, Lind BK, Shahar E, Samet JM, Redline S, D’Agostino RB, Newman AB, Lebowitz MD, Pickering TG (2000) Association of sleep-disordered breathing, sleep apnea, and hypertension in a large community-based study. Sleep Heart Health Study. JAMA 283:1829–1836CrossRefPubMed

Shahar E, Whitney CW, Redline S, Lee ET, Newman AB, Javier Nieto F, O’Connor GT, Boland LL, Schwartz JE, Samet JM (2001) Sleep-disordered breathing and cardiovascular disease: cross-sectional results of the Sleep Heart Health Study. Am J Respir Crit Care Med 163:19–25CrossRefPubMed

He J, Kryger MH, Zorick FJ, Conway W, Roth T (1988) Mortality and apnea index in obstructive sleep apnea. Experience in 385 male patients. Chest 94:9–14CrossRefPubMed

Fletcher EC (1996) Obstuctive sleep apnea and cardiovascular disease. Monaldi Arch Chest Dis 51:77–80PubMed

Punjabi NM, Shahar E, Redline S, Gottlieb DJ, Givelber R, Resnick HE (2004) Sleep-disordered breathing, glucose intolerance, and insulin resistance: the Sleep Heart Health Study. Am J Epidemiol 160:521–530CrossRefPubMed

Schafer H, Pauleit D, Sudhop T, Gouni-Berthold I, Ewig S, Berthold HK (2002) Body fat distribution, serum leptin levels and cardiovascular risk factors in men with obstructive sleep apnea. Chest 122:829–839CrossRefPubMed

Kokturk O, Ciftci TU, Mollarecep E, Ciftci B (2005) Elevated C-reactive protein levels and increased cardiovascular risk in patients with obstructive sleep apnea syndrome. Int Heart J 46:801–809CrossRefPubMed

Reaven GM (1988) Role of insulin resistance in human disease. Diabetes 37:1595–1607CrossRefPubMed

Palaniappan L, Carnethon MR, Wang Y, Hanley AJ, Fortmann SP, Haffner SM, Wagenknecht L (2004) Predictors of the incident metabolic syndrome in adults. The insulin resistance atherosclerosis study. Diabetes Care 27:788–793CrossRefPubMed

10.

Dalton M, Cameron AJ, Zimmet PZ, Shaw JE, Jolley D, Dunstan DW, Welborn TA, AusDiab Steering Committee (2003) Waist circumference, waist to hip ratio, and body mass index and their correlation with cardiovascular disease risk in Australian adults. J Intern Med 254:555–563CrossRefPubMed

11.

Klein S, Coppack SW, Mohamed-Ali V, Landt M (1996) Adipose tissue leptin production and plasma leptin kinetics in humans. Diabetes 45:984–987CrossRefPubMed

12.

Schwartz MW, Seeley RJ (1997) Seminars in medicine of the Beth Israel Deaconess Medical Center. Neuroendocrine responses to starvation and weight loss. N Eng J Med 336:1803–1811CrossRef

13.

Considine RV, Sinha MK, Heiman ML, Kriauciunas A, Stephens TW, Nyce MR, Ohannesian JP, Marco CC, McKee LJ, Bauer TL, Caro JF (1996) Serum immunoreactive-leptin concentrations in normal weight and obese humans. N Eng J Med 334(5):292–295CrossRef

14.

Caro JF, Sinha MK, Kolaczynski JW, Zhang PL, Considine RV (1996) Leptin: the tale of an obesity gene. Diabetes 45:1455–1462CrossRefPubMed

15.

Mark AL, Correia ML, Rahmouni K, Haynes WG (2002) Selective leptin resistance: a new concept in leptin physiology with cardiovascular implications. J Hypertens 20:1245–1250CrossRefPubMed

16.

Wallace AM, McMahon AD, Packard CJ, Kelly A, Shepherd J, Gaw A, Sattar N (2001) Plasma leptin and the risk of cardiovascular disease in the west of Scotland coronary prevention study (WOSCOPS). Circulation 104:3052–3056CrossRefPubMed

17.

Correia ML, Rahmouni K (2006) Role of leptin in the cardiovascular and endocrine complications of the metabolic syndrome. Diabetes Obes Metab 8:603–610CrossRefPubMed

18.

Visser M, Bouter LM, McQuillan GM, Wener MH, Harris TB (1999) Elevated C-reactive protein levels in overweight and obese adults. JAMA 282:2131–2135CrossRefPubMed

19.

Danesh J, Whincup P, Walker M, Lennon L, Thomson A, Appleby P, Gallimore JR, Pepys MB (2000) Low grade inflammation and coronary heart disease: prospective study and updated meta-analyses. BMJ 321:199–204CrossRefPubMedPubMedCentral

20.

Libby P, Ridker PM, Maseri A (2002) Inflammation and atherosclerosis. Circulation 105:1135–1143CrossRefPubMed

21.

Wilcox I, McNamara SG, Collins FL, Grunstein RR, Sullivan CE (1998) “Syndrome Z’’: the interaction of sleep apnea, vascular risk factors and heart disease. Thorax 53:S25-S28CrossRefPubMedPubMedCentral

22.

Grunstein R, Wilcox I, Yang TS, Gould Y, Hedner J (1993) Snoring and sleep apnoea in men: association with central obesity and hypertension. Int J Obes Relat Metab Disord 17:533–540PubMed

23.

Peppard PE, Young T, Palta M, Skatrud J (2000) Prospective study of the association between sleep-disordered breathing and hypertension. N Eng J Med 342:1378–1384CrossRef

24.

Tan KC, Chow WS, Lam JC, Lam B, Wong WK, Tam S, Ip MS (2006) HDL dysfunction in obstructive sleep apnea. Atherosclerosis 184:377–382CrossRefPubMed

25.

Al-Delaimy WK, Manson JE, Willett WC, Stampfer MJ, Hu FB (2002) Snoring as a risk factor of type II diabetes mellitus: a prospective study. Am J Epidemiol 155:387–392CrossRefPubMed

26.

Gami AS, Caples SM, Somers VK (2003) Obesity and obstructive sleep apnea. Endocrinol Metab Clin North Am 32(4):869–894CrossRefPubMed

27.

Ip MSM, Lam B, Ng MMT, Lam WK, Tsant KWT, Lam KSL (2002) Obstructive sleep apnea is independently associated with insulin resistance. Am J Respir Crit Care Med 165:670–676CrossRefPubMed

28.

Punjabi NM, Sorkin JD, Katzel L, Goldberg A, Schwartz A, Smith PL (2002) Sleep-disordered breathing and insulin resistance in middle aged and overweight men. Am J Respir Crit Care Med 165:677–682CrossRefPubMed

29.

Tassone F, Lanfranco F, Gianotti L, Pivetti S, Navone F, Rossetto R, Grottoli S, Gai V, Ghigo E, Maccario M (2003) Obstructive sleep apnoea syndrome impairs insulin sensitivity independently of anthropometric variables. Clin Endocrinol (Oxf) 59:374–379CrossRef

30.

Vgontzas AN, Papanicolaou DA, Bixler EO, Hopper K, Lotsikas A, Lin HM, Kales A, Chrousos GP (2000) Sleep apnea, daytime sleepiness and fatigue: relation to visceral obesity, insulin resistance and hypercytokinemia. J Clin Endocrinol Metab 85:1151–1158CrossRefPubMed

31.

McArdle N, Hillman D, Beilin L, Watts G (2007) Metabolic risk factors in obstructive sleep apnea: a matched controlled study. Am J Respir Crit Care Med 175:190–195CrossRefPubMed

32.

Peled N, Kassirer M, Shitrit D, Kogan Y, Shlomi D, Berliner AS, Kramer MR (2007) The association of OSA with insulin resistance, inflammation and metabolic syndrome. Respir Med 101:1696–1701CrossRefPubMed

33.

Phillips BG, Kato M, Narkiewicz K, Choe I, Somers VK (2000) Increases in leptin levels, sympathetic drive and weight gain in obstructive sleep apnea. Am J Physiol Heart Circ Physiol 279:H234–H237PubMed

34.

Ip MS, Lam KS, Ho C, Tseng KW, Lam W (2000) Serum leptin and vascular risk factors in obstructive sleep apnea. Chest 118:580–586CrossRefPubMed

35.

Chin K, Shimizu K, Nakamura T, Narai N, Masuzaki H, Ogawa Y, Mishima M, Nakamura T, Nakao K, Ohi M (1999) Changes in intra-abdominal visceral fat and serum leptin levels in patients with obstructive sleep apnea syndrome following nasal continuous positive airway pressure therapy. Circulation 100:706–712CrossRefPubMed

36.

Ozturk L, Murat U, Tamer L, Celicoglu F (2003) The association of the severity of obstructive sleep apnea with plasma leptin levels. Arch Otolaryngol Head Neck Surg 129:538–540CrossRefPubMed

37.

Shamsuzzaman AS, Winnicki M, Lanfranchi P, Wolk R, Kara T, Accurso V, Somers VK (2002) Elevated C-reactive protein in patients with obstructive sleep apnea. Circulation 105:2462–2464CrossRefPubMed

38.

Yokoe T, Minoguchi K, Matsuo H, Oda N, Minoguchi H, Yoshino G, Hirano T, Adachi M (2003) Elevated levels of C-reactive protein and interleukin-6 in patients with obstructive sleep apnea syndrome are decreased by nasal continuous positive airway pressure. Circulation 107:1129–1134CrossRefPubMed

39.

Punjabi NM, Beamer BA (2007) C-reactive protein is associated with sleep disordered breathing independent of obesity. Sleep 30:29–34CrossRefPubMed

40.

Stoohs RA, Facchini F, Guilleminault C (1996) Insulin resistance and sleep-disordered breathing in healthy humans. Am J Respir Crit Care Med 154:170–174CrossRefPubMed

41.

Davies RJO, Turner R, Crosby J, Stradling JR (1994) Plasma insulin and lipid levels in untreated obstructive sleep apnoea and snoring: their comparison with matched controls and response to treatment. J Sleep Res 3:180–185CrossRefPubMed

42.

Coughlin SR, Mawdsley L, Mugarza JA, Calverley PM, Wilding JP (2004) Obstructive sleep apnoea is independently associated with an increased prevalence of metabolic syndrome. Eur Heart J 25:735–741CrossRefPubMed

43.

Gruber A, Horwood F, Sithole J, Ali NJ, Idris I (2006) Obstructive sleep apnoea is independently associated with the metabolic syndrome but not insulin resistance state. Cardiovasc Diabetol 5:22–27CrossRefPubMedPubMedCentral

44.

Sharma SK, Kumpawat S, Coel A, Banga A, Ramakrishnan L, Chaturvedi P (2007) Obesity, and not obstructive sleep apnea, is responsible for metabolic abnormalities in a cohort with sleep-disordered breathing. Sleep Med 8:12–17CrossRefPubMed

45.

46.

Sanner BM, Kollhoser P, Buechner N, Zidek W, Tepel M (2004) Influence of treatment on leptin levels in patients with obstructive sleep apnea. Eur Respir J 23:601–604CrossRefPubMed

47.

Barcelo A, Barbe F, Llompart E, de la Pena M, Duran-Cantolla J, Ladaria A, Bosch M, Guerra L, Agusti AG (2005) Neuropeptide Y and leptin in patients with obstructive sleep apnea syndrome: role of obesity. Am J Respir Crit Care Med 171:183–187CrossRefPubMed

48.

Harsch I, Konturek P, Koebnick C, Kuehnlein PP, Fuchs FS, Pour Schahin S, Wiest GH, Hahn EG, Lohmann T, Ficker JH (2003) Leptin and ghrelin levels in patients with obstructive sleep apnoea: effect of CPAP treatment. Eur Respir J 22:251–257CrossRefPubMed

49.

Guilleminault C, Kirisoglu C, Ohayon MM (2004) C-reactive protein and sleep-disordered breathing. Sleep 27:1507–1511CrossRefPubMed

50.

Ryan S, Nolan GM, Hannigan E, Cunningham S, Taylor C, McNicholas WT (2007) Cardiovasular risk markers in obstructive sleep apnoea and correlation with obesity. Thorax 62:509–514CrossRefPubMedPubMedCentral

51.

Chung S, Yoon IY, Shin YK, Lee CH, Kim JW, Lee T, Choi DJ, Ahn HJ (2007) Endothelial dysfunction and C-reactive protein in relation with the severity of obstructive sleep apnea. Sleep 30:997–1001CrossRefPubMedPubMedCentral

52.

Ascaso JF, Romero P, Real JT, Lorente RI, Martinez-Valls J, Carmena R (2003) Abdominal obesity, insulin resistance and metabolic syndrome in a southern European population. Eur J Intern Med 14:101–106CrossRefPubMed

53.

Kaditis A, Alexopoulos E, Damani E, Karadonta I, Kostadima E, Tsolakidou A, Gourgoulianis K, Syrogiannopoulou GA (2005) Obstructive sleep-disordered breathing and fasting insulin levels in nonobese children. Pediatr Pulmonol 40:515–523CrossRefPubMed

54.

Tauman R, O’Brien L, Ivanenko A, Gozal D (2005) Obesity rather than sleep-disordered breathing as the major determinant of insulin resistance and altered lipidemia in snoring children. Pediatrics 116:e66–e73CrossRefPubMed

55.

Parish JM, Adam T, Facchiano L (2007) Relationship of metabolic syndrome and obstructive sleep apnea. J Clin Sleep Med 3:467–472PubMedPubMedCentral

56.

Hatipoğlu U, Rubinstein I (2003) Inflammation and obstructive sleep apnea syndrome pathogenesis: a working hypothesis. Respiration 70:665–671CrossRefPubMed

57.

Luo JD, Zhang GS, Chen MS (2005) Leptin and cardiovascular disease. Drug News Perspect 18:427–431CrossRefPubMed

58.

Tatsumi K, Kasahara Y, Kurosu K, Tanabe N, Takiguchi Y, Kuriyama T (2005) Sleep oxygen desaturation and circulating leptin in obstructive sleep apnea–hypopnea syndrome. Chest 127:716–721CrossRefPubMed

59.

Bhakdi S, Torzewski M, Klouche M, Hemmes M (1999) Complement and atherogenesis: binding of CRP to degraded, nonoxidized LDL enhances complement activation. Arterioscler Thromb Vasc Biol 19:2348–2354CrossRefPubMed

60.

Pasceri V, Cheng JS, Willerson JT, Yeh ET, Chang J (2001) Modulation of C-reactive protein-mediated monocyte chemoattractant protein-1 induction in human endothelial cells by anti-atherosclerosis drugs. Circulation 103:2531–2534CrossRefPubMed

61.

Torzewski M, Rist C, Mortensen RF, Zwaka TP, Bienek M, Waltenberger J, Koenig W, Schmitz G, Hombach V, Torzewski J (2000) C-reactive protein in the arterial intima: role of C-reactive protein receptor-dependent monocyte recruitment in atherogenesis. Arterioscler Thromb Vasc Biol 20:2094–2099CrossRefPubMed

62.

Castell JV, Gomez-Lechon MJ, David M, Fabra R, Trullenque R, Heinrich PC (1990) Acute phase response of human hepatocytes: regulation of acute-phase protein synthesis by interleukin-6. Hepatology 12:1179–1186CrossRefPubMed

63.

Lavie L (2003) Obstructive sleep apnoea syndrome—an oxidative stress disorder. Sleep Med Rev 7:35–51CrossRefPubMed

64.

Polotsky V, Li J, Punjabi N, Rubin AE, Smith PL, Schwartz AR, O’Donnell CP (2003) Intermittent hypoxia increases insulin resistance in genetically obese mice. J Physiol 552:253–264CrossRefPubMedPubMedCentral

65.

Wisse BE (2004) The inflammatory syndrome: the role of adipose cytokines in metabolic disorders liked to obesity. J Am Soc Nephrol 15:2792–2800CrossRefPubMed

66.

Barzilai N, Wang J, Massilon D, Vuguin P, Hawkins M, Rossetti L (1997) Leptin selectively decreases visceral obesity and enhances insulin sensitivity. J Clin Invest 100:3105–3110CrossRefPubMedPubMedCentral

67.

Lichnovská R, Gwozdziewiczová S, Chlup R, Hrebicek J (2005) Serum leptin in the development of insulin resistance and other disorders in the metabolic syndrome. Biomed Papers 149:119–126CrossRef

68.

Bonora E, Targher G, Alberiche M, Bonadonna RC, Saggiani F, Zenere MB, Monauni T, Muggeo M (2000) Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity. Diabetes Care 23:57–63CrossRefPubMed

Titel: Association of Sleep Apnea Severity and Obesity with Insulin Resistance, C-Reactive Protein, and Leptin Levels in Male Patients with Obstructive Sleep Apnea
verfasst von: Fotis Kapsimalis
George Varouchakis
Asimina Manousaki
Spiros Daskas
Dimitra Nikita
Meir Kryger
Konstantinos Gourgoulianis
Publikationsdatum: 01.08.2008
Verlag: Springer New York
Erschienen in: Lung / Ausgabe 4/2008
Print ISSN: 0341-2040
Elektronische ISSN: 1432-1750
DOI: https://doi.org/10.1007/s00408-008-9082-x

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Innere Medizin

Echinokokkose medikamentös behandeln oder operieren?

06.05.2024 DCK 2024 Kongressbericht

Die Therapie von Echinokokkosen sollte immer in spezialisierten Zentren erfolgen. Eine symptomlose Echinokokkose kann – egal ob von Hunde- oder Fuchsbandwurm ausgelöst – konservativ erfolgen. Wenn eine Op. nötig ist, kann es sinnvoll sein, vorher Zysten zu leeren und zu desinfizieren.

Umsetzung der POMGAT-Leitlinie läuft

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Proximale Humerusfraktur: Auch 100-Jährige operieren?

01.05.2024 DCK 2024 Kongressbericht

Mit dem demographischen Wandel versorgt auch die Chirurgie immer mehr betagte Menschen. Von Entwicklungen wie Fast-Track können auch ältere Menschen profitieren und bei proximaler Humerusfraktur können selbst manche 100-Jährige noch sicher operiert werden.

Die „Zehn Gebote“ des Endokarditis-Managements

30.04.2024 Endokarditis Leitlinie kompakt

Worauf kommt es beim Management von Personen mit infektiöser Endokarditis an? Eine Kardiologin und ein Kardiologe fassen die zehn wichtigsten Punkte der neuen ESC-Leitlinie zusammen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Springer Medizin

Abstract

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 4/2008

Effects of High-Frequency Oscillatory Ventilation on Oleic Acid-Induced Lung Injury in Sheep

Benign Metastasizing Leiomyoma

Interleukin-12 Receptor β1 Polymorphisms and Nontuberculous Mycobacterial Lung Diseases

Drinking Influences Exhaled Breath Condensate Acidity

Effects of Mechanical Ventilation on the Electrocardiogram in Adults